These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21071721)

  • 1. Body weight, not thrombus-burden tissue plasminogen activator dosing: but still.
    Alexandrov AV; Tsivgoulis G
    Stroke; 2010 Dec; 41(12):2723-4. PubMed ID: 21071721
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl.
    Golomb MR; Rafay M; Armstrong D; Massicotte P; Curtis R; Hune S; deVeber GA
    J Child Neurol; 2003 Jun; 18(6):420-3. PubMed ID: 12886978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight approximation in stroke before thrombolysis: the WAIST-Study: a prospective observational "dose-finding" study.
    Breuer L; Nowe T; Huttner HB; Blinzler C; Kollmar R; Schellinger PD; Schwab S; Köhrmann M
    Stroke; 2010 Dec; 41(12):2867-71. PubMed ID: 21071723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating patients with ischemic stroke with tissue plasminogen activator in the 3.5- to 4-hour window: numbers support benefit but the message is to still go fast.
    Kurth T; Tzourio C
    Stroke; 2009 Jul; 40(7):2295-6. PubMed ID: 19498185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recombinant tissue plasminogen activator for thrombolytic therapy of right atrial thrombus in a neonate and infant].
    Karolczak MA; Motylewicz B; Madry W; Wieteska J; Klemińska M
    Pediatr Pol; 1996 May; 71(5):465-9. PubMed ID: 8710431
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants.
    Bose J; Clarke P
    Pediatr Crit Care Med; 2011 Nov; 12(6):e407-9. PubMed ID: 21131893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents].
    Araki G
    No To Shinkei; 1992 Sep; 44(9):771-7. PubMed ID: 1476806
    [No Abstract]   [Full Text] [Related]  

  • 10. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue-plasminogen activator fibrinolysis.
    Osher RH
    J Cataract Refract Surg; 1999 Jul; 25(7):880. PubMed ID: 10404358
    [No Abstract]   [Full Text] [Related]  

  • 12. Good outcome in early pregnancy following direct thrombolysis for cerebral venous sinus thrombosis.
    Weatherby SJ; Edwards NC; West R; Heafield MT
    J Neurol; 2003 Nov; 250(11):1372-3. PubMed ID: 14648156
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I).
    Murphy SA; Gibson CM; Van de Werf F; McCabe CH; Cannon CP
    Am J Cardiol; 2002 Jul; 90(1):51-4. PubMed ID: 12088781
    [No Abstract]   [Full Text] [Related]  

  • 14. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteplase (Cathflo Activase).
    Middleton G; Ruzevick B
    Clin J Oncol Nurs; 2004 Aug; 8(4):417-8, 420. PubMed ID: 15354930
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous tissue plasminogen activator in central retinal artery occlusion.
    Falavarjani KG; Modarres M
    Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
    [No Abstract]   [Full Text] [Related]  

  • 17. Fragmentation of an intracerebral embolus after IV tissue plasminogen activator treatment.
    Artinian M; Babikian V
    AJR Am J Roentgenol; 2001 Jun; 176(6):1603. PubMed ID: 11373248
    [No Abstract]   [Full Text] [Related]  

  • 18. Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcome.
    Aulicky P; Rabinstein A; Seet RC; Neumann J; Mikulik R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1293-7. PubMed ID: 23246191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-accelerated catheter-directed thrombolysis for the management of postpartum deep venous thrombosis.
    Dumantepe M; Tarhan IA; Yurdakul I; Ozler A
    J Obstet Gynaecol Res; 2013 May; 39(5):1065-9. PubMed ID: 23379969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous recombinant tissue-type plasminogen activator in the extended time window and the US Food and Drug Administration: confused about the time.
    Wechsler LR; Jovin TG
    Stroke; 2012 Sep; 43(9):2517-9. PubMed ID: 22910892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.